Abbott Laboratories on Pace for Largest Percent Decrease Since October 2023 — Data Talk
Abbott Laboratories ABT
News
-
Abbott Labs' first-quarter results top estimates amid strong medical-device sales
Abbott Gets FDA Approval for TriClip Heart Valve Repair System
Abbott Laboratories Cartridge Gets FDA Clearance to be Used with Whole Blood
Here's what families need to know after a landmark $60 million verdict in baby-formula suit
Enfamil maker vows to fight $60 million baby-formula verdict as stock slides
Abbott Laboratories On Track for Largest Percent Decrease Since October 2023 — Data Talk
Abbott Laboratories says FDA independent panel votes to approve heart device
Abbott Laboratories Says FDA Independent Panel Votes to Approve Heart Device
Dow ends lower, S&P 500 squeaks by with fourth straight record close
Abbott Labs Posts Higher 4Q Sales, Despite Soft Demand For Covid Tests
Abbott Labs' fourth-quarter sales top estimates amid strong medical-device demand
Abbott's Volt PFA System Used in Procedures for Patients with Abnormal Heart Rhytms
Abbott Laboratories Increases Dividend 7.8%, to 55 Cents
Who's afraid of Ozempic? From restaurants to package makers, companies work to calm investors' GLP-1 jitters.
FDA Warns Abbott, Infinant Health About Selling Preterm Infant Probiotic Products
Abbott Gets FDA Approval for Blood Cancer Companion Diagnostic
Abbott Labs' stock rises as third-quarter results beat estimates despite plunging COVID sales
Abbott Laboratories on Track for Lowest Close Since July 2020 — Data Talk
These diabetes stocks, pummeled by the Ozempic craze, now look like bargains, analysts say